Athul Thada
Tell me more about Athul Thada?
Athul Thada is a highly experienced professional with 19.9 years of work experience in finance and business services IT. He has held various leadership positions in renowned companies such as NOVO NORDISK SERVICE CENTRE (INDIA) PRIVATE LIMITED, Novo Nordisk, Accenture, and Tata Consultancy Services. Athul has worked in both general management and IT business consulting roles, contributing to the growth and success of these organizations. He is currently based in Bengaluru, Karnataka, India.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Finance & Business Services IT
Work Experience
Director | IT Business Partner
Pharmaceutical Manufacturing
Athul Thada's Professional Milestones
- Software Engineer (2003-12-01~2007-01-01): Created scalable and efficient software solutions, optimizing performance and efficiency for the company's digital transformation efforts.
- Director | IT Business Partner (2017-01-01~2018-11-01): Developed strategic IT partnerships to drive business growth and optimize IT processes for optimal performance.
Certification
Colleagues
Yasmin M.
product owner hos novo nordisk
Thomas Nexø Holm
Hospital Partner | Blockchain Trader | Asset Management | Investor | MBA
Christian L.
Product Owner
Paula de Oliveira Setti
Process Owner | Project Manager | Finance | Supplier Management | Master Data | Compliance | Process Optimization | Stakeholder Management | Training
Trish (Sutrishna) Beebireddy
Business Analyst | Product Owner
Other Named Athul Thada
Frequently asked questions
We found 1 Athul Thada's email addresses
We found 1 Athul Thada's phone numbers
Athul Thada's social media include: Linkedin,
Athul Thada works for Novo Nordisk
Athul Thada's role in Novo Nordisk is Director | IT Business Partner
Athul Thada works in the industry of Pharmaceutical Manufacturing
Athul Thada's colleagues are Yasmin M.,Thomas Nexø Holm,Christian L.
Athul Thada's latest job experience is Director | IT Business Partner at Novo Nordisk